KKilikia Diagnostics
Kilikia Diagnostics is an Elche-based start-up developing a blood-based kit for the early detection of Parkinson's disease. The test measures biological markers before clinical symptoms appear, and a small reader with interpretation software lets neurologists, primary care practices and research centres use it as an initial screening tool. The company was founded by neuroscientists Ani Gasparyan and Álvaro Morcuende and is based at the Scientific Park of Miguel Hernández University (UMH). In 2026 it won several prizes at the 15th UMH Start-up Creation Marathon, including the Santander X Spain Awards – Startup Universitaria 2026. To date it has been funded through these prizes and the founders' own resources.
SectorsHealthtech, Diagnostics, Medtech, Neurology
Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing
Founders
A
Ani Gasparyan
Co-founder
Á
Álvaro Morcuende
Co-founder
Global models 5
QQuanterix
United States · www.quanterix.com ↗
Sells ultrasensitive blood-biomarker assay kits plus its own Simoa reader instruments and software to labs and research centres, a kit-plus-reader model widely used for neurodegeneration markers such as NfL and pTau.
$106MComparable
SSpear Bio
United States · spear.bio ↗
Develops ultrasensitive blood tests for early detection of neurodegenerative disease (pTau217 for Alzheimer's, plus Parkinson's-related assays) and sells them as kits to clinical and research labs.
$45MComparable
CCND Life Sciences
United States · cndlifesciences.com ↗
Sells a biomarker test (Syn-One, which finds abnormal alpha-synuclein in a skin biopsy) that neurologists use to diagnose Parkinson's and related synucleinopathies early.
$26MComparable
CC2N Diagnostics
United States · c2n.com ↗
Sells blood tests (Precivity) that detect Alzheimer's pathology early to neurologists and primary care doctors, the same blood-based early-screening model applied to a different neurodegenerative disease.
raised —Comparable
AAmprion
United States · ampriondx.com ↗
Sells an alpha-synuclein seed amplification test that detects Parkinson's and Lewy body pathology, used by neurologists and pharma trials for early and differential diagnosis.
raised —Comparable
In the same niche 50 others
Most funded firstSee all 51 in Diagnostics & precision medicine testing →
Investors
No investors found yet.
Funding rounds
No announced rounds on record.
News 2
Open as list →| Published | Article |
|---|---|
| 2026-07-04 |
Kilikia, la startup de la UMH que busca desarrollar un kit de detección temprana del Parkinson ↗
Alicante Plaza
2026-07-04 |
| 2026-06-10 |
La Maratón de Start-ups UMH premia un kit de diagnóstico temprano del párkinson ↗
Alicante Plaza
2026-06-10 |